What neoadjuvant chemotherapy do you suggest for a rapidly growing triple-negative breast cancer?
Would you give pembrolizumab with chemotherapy or just chemotherapy? The patient had a history of mantle radiation several years ago.
Answer from: Medical Oncologist at Academic Institution
If the patient has non-metastatic, operable triple-negative breast cancer that is at least 2 cm in diameter or positive for axillary lymph node metastases, I would use the KEYNOTE-522 regimen (1 year of pembrolizumab in combination with 4 cycles of neo-adjuvant paclitaxel, carboplatin followed by 4 ...
Comments
Medical Oncologist at Duke University Medical Center KEYNOTE-522 is the state-of-the-art treatment for ...
Medical Oncologist at Los Angeles VA Medical Center Dr. @Robert Wesolowski and Dr. @Gretchen G. Kimmic...
KEYNOTE-522 is the state-of-the-art treatment for ...
Dr. @Robert Wesolowski and Dr. @Gretchen G. Kimmic...